Skip to main content
Erschienen in: Reactions Weekly 1/2014

01.12.2014 | Case report

Fluorouracil/folinic-acid/irinotecan/regorafenib

Hand-foot skin reaction and fatigue: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Excerpt

A 66-year-old man developed hand-foot skin reaction and fatigue while receiving fluorouracil, folinic acid, irinotecan and regorafenib. …
Literatur
Zurück zum Zitat Lu C-Y, et al. FOLFIRI and regorafenib combination therapy with dose escalation of irinotecan as fourth-line treatment for patients with metastatic colon cancer according to UGT1A1 genotyping. OncoTargets and Therapy 7: 2143-2146, 21 Nov 2014 - TaiwanPubMedCentralPubMed Lu C-Y, et al. FOLFIRI and regorafenib combination therapy with dose escalation of irinotecan as fourth-line treatment for patients with metastatic colon cancer according to UGT1A1 genotyping. OncoTargets and Therapy 7: 2143-2146, 21 Nov 2014 - TaiwanPubMedCentralPubMed
Metadaten
Titel
Fluorouracil/folinic-acid/irinotecan/regorafenib
Hand-foot skin reaction and fatigue: case report
Publikationsdatum
01.12.2014
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2014
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-014-5915-y

Weitere Artikel der Ausgabe 1/2014

Reactions Weekly 1/2014 Zur Ausgabe

Case report

Carfilzomib

Case report

Ibuprofen

Case report

Heparin

Case report

Atomoxetine

Case report

Arsenic trioxide